Pacific Edge Ltd
NZX:PEB
Pacific Edge Ltd
Operating Expenses
Pacific Edge Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pacific Edge Ltd
NZX:PEB
|
Operating Expenses
-NZ$52.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-17%
|
|
|
Aroa Biosurgery Ltd
ASX:ARX
|
Operating Expenses
-NZ$69.6m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
Pacific Edge Ltd
Glance View
Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. The firm develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. The firm's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and operation of the laboratories used for the detection of bladder cancer in the United States and New Zealand. The company offers Cxbladder, which is a suite of non-invasive laboratory tests for the detection and the management of bladder cancer. Cxbladder includes a suite of urine-based molecular tests to determine the likelihood of bladder cancer in patients presenting with hematuria. Its pipeline includes Cxcolorectal, which is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer, enabling prediction of aggressiveness of the tumor.
See Also
What is Pacific Edge Ltd's Operating Expenses?
Operating Expenses
-52.8m
NZD
Based on the financial report for Sep 30, 2024, Pacific Edge Ltd's Operating Expenses amounts to -52.8m NZD.
What is Pacific Edge Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-17%
Over the last year, the Operating Expenses growth was 11%. The average annual Operating Expenses growth rates for Pacific Edge Ltd have been -26% over the past three years , -18% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet